2021 annual financial data
ADMA Biologics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -138.82%.
Operating income was -58,374,000 USD and net income was -71,648,000 USD.
Operating cash flow was -112,368,982 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 80,943,000 USD
- Operating income
- -58,374,000 USD
- Net income
- -71,648,000 USD
- Operating cash flow
- -112,368,982 USD